Farther Finance Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.07K | Sell |
210
-14
| -6% | -$605 | ﹤0.01% | 3115 |
|
|
2025
Q1 | $7.4K | Buy |
224
+24
| +12% | +$792 | ﹤0.01% | 2876 |
|
|
2024
Q4 | $5.49K | Buy |
200
+63
| +46% | +$1.73K | ﹤0.01% | 2627 |
|
|
2024
Q3 | $3.47K | Buy |
137
+41
| +43% | +$1.04K | ﹤0.01% | 2791 |
|
|
2024
Q2 | $2.42K | Buy |
96
+5
| +5% | +$126 | ﹤0.01% | 2714 |
|
|
2024
Q1 | $2.73K | Sell |
91
-5
| -5% | -$150 | ﹤0.01% | 2360 |
|
|
2023
Q4 | $3.88K | Buy |
96
+91
| +1,820% | +$3.67K | ﹤0.01% | 2098 |
|
|
2023
Q3 | $132 | Buy |
+5
| New | +$132 | ﹤0.01% | 2525 |
|